NCT00296608 Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer Status COMPLETED Phase PHASE3
NCT00296062 Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer Status TERMINATED Phase PHASE1
NCT00290615 Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00285701 Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study Status COMPLETED Phase PHASE1/PHASE2
NCT00284258 Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00280761 Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy Status COMPLETED Phase N/A
NCT00280176 Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer Status COMPLETED Phase PHASE1
NCT00278889 Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) Status COMPLETED Phase PHASE2
NCT00277303 Study of XL999 in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00276861 Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer Status TERMINATED Phase PHASE2
NCT00274872 Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00268463 Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer Status TERMINATED Phase PHASE3
NCT00268398 Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases Status COMPLETED Phase PHASE3
NCT00268333 Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00265824 Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM) Status COMPLETED Phase PHASE3